[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598898":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":36,"collaborators":39,"id":47,"slug":7,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":7,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":7,"maxAge":7,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Tongji Hospital","OTHER",null,[9],{"type":10,"name":11,"description":11,"armGroupLabels":7,"otherNames":7},"DRUG","real word drugs",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Yikai Yu","CONTACT","86-027-83665519","yuyikai@163.com",[19],{"facility":5,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Wuhan","Hubei","430030","China","CN",{"type":27,"coordinates":28},"Point",[29,30],114.26667,30.58333,{"lat":30,"lon":29},[33],{"name":34,"role":15,"phone":35,"phoneExt":7,"email":17},"YIKAI YU","15617678920",{"type":37,"investigatorFullName":34,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Doctor",[40,42,45],{"name":41,"class":6},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",{"name":43,"class":44},"Pfizer","INDUSTRY",{"name":46,"class":6},"Johns Hopkins University","100598898",false,"NCT07077473","Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases","A Retrospective Study Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases","Inclusion Criteria:\n\n\\- Clinical diagnosis of Familial Mediterranean fever (FMF) patients (Tel Hashomer criteria)\n\nExclusion Criteria:\n\n* Have a history of mental illness, or alcohol and drug dependence；\n* Pregnant, with severe infection, severe cardiac insufficiency, severe liver or kidney dysfunction；\n* Complicated with tumors, organ transplants, etc. which have significant impact on the immune system or require the use of immunosuppressants.","ALL",{"count":55,"type":56},12,"ESTIMATED","OBSERVATIONAL","retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world",[60],"Familial Mediterranean Fever (FMF )","2026-01-25",{"date":63,"type":64},"2026-01-27","ACTUAL",{"date":66,"type":64},"2018-01-01",{"date":68,"type":56},"2026-12-31",{"name":5,"class":6},1]